Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
California is looking to bolster its struggling cannabis market, Australia made psychedelic history, and Pennsylvania inched toward recreational legalization.
The bill is Haney’s solution to California’s struggling cannabis industry. As it currently stands, high taxes and a mix of other factors have made it difficult for legal dispensary owners to keep up with the low prices of the illicit market. The bill, Haney says, would allow dispensaries to diversify their businesses and draw in curious visitors who may not come otherwise.
Haney’s bill already has the support of many in the state, like San Francisco Supervisor Rafael Mandelman. “I think those (current) restrictions don’t make sense and they’re not helpful to the lounges,” Mandelman said. The Supervisor sees a future where the bill makes dispensaries more enjoyable spaces and in turn allows for further economic developments.
A handful of California cities like West Hollywood and Palm Springs have already passed ordinances legalizing cannabis cafes if the state permits them. If Haney’s bill were to pass, these cities would be the first to benefit. Still, nothing is certain, as Gov. Gavin Newsom ultimately gets the final say on the bill.
What do you think of Haney’s proposed “cannabis cafe” bill? Would something like this make you more interested in visiting a dispensary? Let us know in the comments!
Australia Becomes First Nation to Legalize MDMA and Psilocybin
Late last week, Australia became the first country to approve MDMA and psilocybin for medical use. Starting July 1, authorized psychiatrists will be able to prescribe the substances to patients dealing with certain mental health issues, like PTSD.
See If You Qualify For Medical Marijuana -Select Your State!
The move comes as researchers have gathered increasing evidence that shows both MDMA and psilocybin’s therapeutic properties. A 2022 study, for example, found that psilocybin can help patients struggling with treatment-resistant depression. A separate study found that MDMA can help reduce the odds of psychological distress and suicidal thoughts.
With Australia breaking the barrier, more countries are expected to follow suit. In the U.S., experts predict that MDMA could gain FDA approval and be available in hospitals as soon as 2024.
What do you think of Australia’s history-making move? When do you think we’ll see something like this in the U.S.?
Legal Experts Eye Pennsylvania as Next Recreational State
Lastly, a group of legal experts says Pennsylvania could be the next state to legalize recreational cannabis.
The report comes from Clark Hill, an international team of business-focused legal advisors. The report notes a number of contributing factors that have positioned the state to enter the recreational cannabis sphere.
One of the biggest factors is the state’s recently elected Democratic governor, Josh Shapiro. With the previous governor also being a Democrat, the report speculates momentum could continue to build to legalize cannabis and other cannabis-adjacent industries. Better yet, incoming Gov. Shapiro has already vocalized his full support for the hemp industry.
Beyond politics, the report also noted Pennsylvania’s ever-growing medical cannabis program as another sign the state may be ready for more. In its first year alone, Pennsylvania’s medical cannabis program earned $132 million in sales and $2 million in tax revenue. Since then, the program has only gotten bigger, amassing $900 million in sales between 2020 and 2021.
Make sure to check in with Veriheal to stay up to date with the latest cannabis news out of Pennsylvania.
Mexico-born and California-raised, Cesar is a Marketing Associate at Veriheal. When he’s not scouring social media for the latest internet drama, you can find him working on yet another collage project.
Have you ever consumed cannabis and gotten a little too high for your liking? Or have you ever needed to calm down a friend who consumed too much weed for their tolerance level? If so, we’ve got you covered. Although an overdose (taking more than what is medically recommended) of delta-9 tetrahydrocannabinol (THC) is not…
When Piper Lindeen’s son Zach began showing medical issues at just three years old, no one suspected a rare, severe form of epilepsy. Doctors initially didn’t recognize his symptoms as seizures. Eventually, they diagnosed Zach with epilepsy—but by then, his condition had worsened from a few seizures a week to several each day. As it…
Over the years, Hollywood has had a mixed relationship with cannabis. Portrayals have run the gamut from weed as the devil’s lettuce, able to ruin your life and destroy your mind after just a single puff, to a beneficial, life-giving MacGuffin. Because American audiences have such wide-ranging attitudes towards weed— according to the Pew Research…
You may think that when someone has a medical cannabis card, they are able to use cannabis however their medical practitioner sees fit. However, this is not always the case! Depending on someone’s employment and place of work, they may not be able to use cannabis, even if they were to obtain a medical cannabis…
In January, the US Food and Drug Administration (FDA) approved the Johnson & Johnson brand nasal spray, Spravato®, as the world’s first and only monotherapy for addressing treatment-resistant cases of major depressive disorder (MDD). In 2019, the FDA approved Spravato to treat treatment-resistant depression (TRD), with optional uses alone or alongside oral antidepressant medication (both…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.